Photoredox catalysis may be a general mechanism in photodynamic therapy.

ABSTRACT: Elucidating the underlying photochemical mechanisms of action (MoA) of photodynamic therapy (PDT) may allow its efficacy to be improved and could set the stage for the development of new classes of PDT photosensitizers. Here, we provide evidence that "photoredox catalysis in cells," wherein key electron transport pathways are disrupted, could constitute a general MoA associated with PDT. Taking the cellular electron donor nicotinamide adenine dinucleotide as an example, we have found that well-known photosensitizers, such as Rose Bengal, BODIPY, phenoselenazinium, phthalocyanine, and porphyrin derivatives, are able to catalyze its conversion to NAD⁺. This MoA stands in contrast to conventional type I and type II photoactivation mechanisms involving electron and energy transfer,

SUBMITTER: Li M 

PROVIDER: S-EPMC9407644 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature